{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T11:57:10Z","timestamp":1789732630936,"version":"4.0.1"},"reference-count":8,"publisher":"American Society of Hematology","issue":"12","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2003,6,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Protein Z deficiencies have recently been described in women with unexplained early fetal loss. Using a new, specifically elaborated, commercially available enzyme-linked immunosorbent assay (ELISA), we performed a case-control study on anti\u2013protein Z immunoglobulin G (IgG) and IgM antibodies in 191 nonthrombotic, nonthrombophilic women with consecutive pathologic pregnancies. Levels of anti\u2013protein Z antibodies were categorized in 3 strata (percentiles 1 through 74, 75 through 97, 98 through 100 among controls). The 2 upper levels of IgG and IgM anti\u2013protein Z antibodies were associated with the risk of unexplained recurrent embryo loss or fetal death independently from habitual antiphospholipid\/anticofactor antibodies, and a dose-effect relationship between antibody levels and the clinical risks was evidenced. In women, enhanced immune-complex formation with protein Z may play a role in unexplained embryo losses and, from the 10th week of gestation, may favor hypercoagulability in the maternal placenta side.<\/jats:p>","DOI":"10.1182\/blood-2002-12-3802","type":"journal-article","created":{"date-parts":[[2003,3,10]],"date-time":"2003-03-10T21:12:56Z","timestamp":1047330776000},"page":"4850-4852","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":45,"title":["Anti\u2013protein Z antibodies in women with pathologic pregnancies"],"prefix":"10.1182","volume":"101","author":[{"given":"Jean-Christophe","family":"Gris","sequence":"first","affiliation":[{"name":"From the Laboratoire d'He\u0301matologie, Unite\u0301 de Formation et de Recherche (UFR) des sciences pharmaceutiques et biologiques, Universite\u0301 Montpellier 1, Montpellier, France; Laboratoire d'He\u0301matologie, Centre Hospitalier Universitaire (CHU) de Ni\u0302mes, France; the EA 2992 (\u201cDynamique des incohe\u0301rences cardiovasculaires\u201d), Ni\u0302mes, France; the De\u0301partement de Gyne\u0301cologie et Obste\u0301trique, CHU de Ni\u0302mes, France; and Hyphen BioMed, Andre\u0301sy; France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ce\u0301cile","family":"Amadio","sequence":"additional","affiliation":[{"name":"From the Laboratoire d'He\u0301matologie, Unite\u0301 de Formation et de Recherche (UFR) des sciences pharmaceutiques et biologiques, Universite\u0301 Montpellier 1, Montpellier, France; Laboratoire d'He\u0301matologie, Centre Hospitalier Universitaire (CHU) de Ni\u0302mes, France; the EA 2992 (\u201cDynamique des incohe\u0301rences cardiovasculaires\u201d), Ni\u0302mes, France; the De\u0301partement de Gyne\u0301cologie et Obste\u0301trique, CHU de Ni\u0302mes, France; and Hyphen BioMed, Andre\u0301sy; France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Mercier","sequence":"additional","affiliation":[{"name":"From the Laboratoire d'He\u0301matologie, Unite\u0301 de Formation et de Recherche (UFR) des sciences pharmaceutiques et biologiques, Universite\u0301 Montpellier 1, Montpellier, France; Laboratoire d'He\u0301matologie, Centre Hospitalier Universitaire (CHU) de Ni\u0302mes, France; the EA 2992 (\u201cDynamique des incohe\u0301rences cardiovasculaires\u201d), Ni\u0302mes, France; the De\u0301partement de Gyne\u0301cologie et Obste\u0301trique, CHU de Ni\u0302mes, France; and Hyphen BioMed, Andre\u0301sy; France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge\u0301raldine","family":"Lavigne-Lissalde","sequence":"additional","affiliation":[{"name":"From the Laboratoire d'He\u0301matologie, Unite\u0301 de Formation et de Recherche (UFR) des sciences pharmaceutiques et biologiques, Universite\u0301 Montpellier 1, Montpellier, France; Laboratoire d'He\u0301matologie, Centre Hospitalier Universitaire (CHU) de Ni\u0302mes, France; the EA 2992 (\u201cDynamique des incohe\u0301rences cardiovasculaires\u201d), Ni\u0302mes, France; the De\u0301partement de Gyne\u0301cologie et Obste\u0301trique, CHU de Ni\u0302mes, France; and Hyphen BioMed, Andre\u0301sy; France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herve\u0301","family":"De\u0301chaud","sequence":"additional","affiliation":[{"name":"From the Laboratoire d'He\u0301matologie, Unite\u0301 de Formation et de Recherche (UFR) des sciences pharmaceutiques et biologiques, Universite\u0301 Montpellier 1, Montpellier, France; Laboratoire d'He\u0301matologie, Centre Hospitalier Universitaire (CHU) de Ni\u0302mes, France; the EA 2992 (\u201cDynamique des incohe\u0301rences cardiovasculaires\u201d), Ni\u0302mes, France; the De\u0301partement de Gyne\u0301cologie et Obste\u0301trique, CHU de Ni\u0302mes, France; and Hyphen BioMed, Andre\u0301sy; France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Me\u0301de\u0301ric","family":"Hoffet","sequence":"additional","affiliation":[{"name":"From the Laboratoire d'He\u0301matologie, Unite\u0301 de Formation et de Recherche (UFR) des sciences pharmaceutiques et biologiques, Universite\u0301 Montpellier 1, Montpellier, France; Laboratoire d'He\u0301matologie, Centre Hospitalier Universitaire (CHU) de Ni\u0302mes, France; the EA 2992 (\u201cDynamique des incohe\u0301rences cardiovasculaires\u201d), Ni\u0302mes, France; the De\u0301partement de Gyne\u0301cologie et Obste\u0301trique, CHU de Ni\u0302mes, France; and Hyphen BioMed, Andre\u0301sy; France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Que\u0301re\u0301","sequence":"additional","affiliation":[{"name":"From the Laboratoire d'He\u0301matologie, Unite\u0301 de Formation et de Recherche (UFR) des sciences pharmaceutiques et biologiques, Universite\u0301 Montpellier 1, Montpellier, France; Laboratoire d'He\u0301matologie, Centre Hospitalier Universitaire (CHU) de Ni\u0302mes, France; the EA 2992 (\u201cDynamique des incohe\u0301rences cardiovasculaires\u201d), Ni\u0302mes, France; the De\u0301partement de Gyne\u0301cologie et Obste\u0301trique, CHU de Ni\u0302mes, France; and Hyphen BioMed, Andre\u0301sy; France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Amiral","sequence":"additional","affiliation":[{"name":"From the Laboratoire d'He\u0301matologie, Unite\u0301 de Formation et de Recherche (UFR) des sciences pharmaceutiques et biologiques, Universite\u0301 Montpellier 1, Montpellier, France; Laboratoire d'He\u0301matologie, Centre Hospitalier Universitaire (CHU) de Ni\u0302mes, France; the EA 2992 (\u201cDynamique des incohe\u0301rences cardiovasculaires\u201d), Ni\u0302mes, France; the De\u0301partement de Gyne\u0301cologie et Obste\u0301trique, CHU de Ni\u0302mes, France; and Hyphen BioMed, Andre\u0301sy; France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Dauzat","sequence":"additional","affiliation":[{"name":"From the Laboratoire d'He\u0301matologie, Unite\u0301 de Formation et de Recherche (UFR) des sciences pharmaceutiques et biologiques, Universite\u0301 Montpellier 1, Montpellier, France; Laboratoire d'He\u0301matologie, Centre Hospitalier Universitaire (CHU) de Ni\u0302mes, France; the EA 2992 (\u201cDynamique des incohe\u0301rences cardiovasculaires\u201d), Ni\u0302mes, France; the De\u0301partement de Gyne\u0301cologie et Obste\u0301trique, CHU de Ni\u0302mes, France; and Hyphen BioMed, Andre\u0301sy; France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Mare\u0300s","sequence":"additional","affiliation":[{"name":"From the Laboratoire d'He\u0301matologie, Unite\u0301 de Formation et de Recherche (UFR) des sciences pharmaceutiques et biologiques, Universite\u0301 Montpellier 1, Montpellier, France; Laboratoire d'He\u0301matologie, Centre Hospitalier Universitaire (CHU) de Ni\u0302mes, France; the EA 2992 (\u201cDynamique des incohe\u0301rences cardiovasculaires\u201d), Ni\u0302mes, France; the De\u0301partement de Gyne\u0301cologie et Obste\u0301trique, CHU de Ni\u0302mes, France; and Hyphen BioMed, Andre\u0301sy; France."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021218225649400_REF1","doi-asserted-by":"crossref","unstructured":"Han X, Huang ZF, Broze GJ Jr. Characterization of protein Z-dependent protease inhibitor. Blood. 2000;96: 3049-3055.","DOI":"10.1182\/blood.V96.9.3049"},{"key":"2020021218225649400_REF2","doi-asserted-by":"crossref","unstructured":"Broze GJ Jr. Protein Z-dependent regulation of coagulation. Thromb Haemost. 2001;86: 8-13.","DOI":"10.1055\/s-0037-1616195"},{"key":"2020021218225649400_REF3","doi-asserted-by":"crossref","unstructured":"Gris JC, Que\u0301re\u0301 I, De\u0301chaud H, et al. High frequency of protein Z deficiency in patients with unexplained early fetal loss. Blood. 2002;99: 2606-2608.","DOI":"10.1182\/blood.V99.7.2606"},{"key":"2020021218225649400_REF4","doi-asserted-by":"crossref","unstructured":"Gris JC, Ripart-Neveu S, Maugard C, et al Prospective evaluation of the prevalence of haemostasis abnormalities in unexplained primary early recurrent miscarriages: The Ni\u0302mes Obstetricians and Haematologists Study (NOHA). Thromb Haemost. 1997;77: 1096-1103.","DOI":"10.1055\/s-0038-1656119"},{"key":"2020021218225649400_","doi-asserted-by":"crossref","unstructured":"Gris JC, Que\u0301re\u0301 I, Monpeyroux F, et al. Casecontrol study of the frequency of thrombophilic disorders in couples with late foetal loss and no thrombotic antecedent: the Ni\u0302mes Obstetricians and Haematologists Study5 (NOHA5). Thromb Haemost. 1999;81: 891-899.","DOI":"10.1055\/s-0037-1614594"},{"key":"2020021218225649400_REF6","doi-asserted-by":"crossref","unstructured":"Gris JC, Que\u0301re\u0301 I, Sanmarco M, et al. Antiphospholipid and antiprotein syndromes in nonthrombotic, non-autoimmune women with unexplained recurrent primary early foetal loss: The Ni\u0302mes Obstetricians and Haematologists Study\u2014 NOHA.Thromb Haemost. 2000;84: 228-236.","DOI":"10.1055\/s-0037-1614001"},{"key":"2020021218225649400_REF7","doi-asserted-by":"crossref","unstructured":"Odorczuk M, Keil LB, DeBariVA. Binding of complement component C1q to anti\u2013beta2-glycoprotein I antibodies from patients with antiphospholipid syndrome. Inflamm Res. 1999;48: 524-526.","DOI":"10.1007\/s000110050497"},{"key":"2020021218225649400_REF8","doi-asserted-by":"crossref","unstructured":"George J, Blank M, Levy Y, et al. Differential effects of anti\u2013beta2-glycoprotein I antibodies on endothelial cells and on the manifestation of experimental antiphospholipid syndrome. Circulation. 1998;97: 900-906.","DOI":"10.1161\/01.CIR.97.9.900"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/101\/12\/4850\/1687813\/h81203004850.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/101\/12\/4850\/1687813\/h81203004850.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T19:29:00Z","timestamp":1581535740000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/101\/12\/4850\/17027\/Antiprotein-Z-antibodies-in-women-with-pathologic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,6,15]]},"references-count":8,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2003,6,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2002-12-3802","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,6,15]]}}}